{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:42:01Z","timestamp":1794271321870,"version":"4.9.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-00456-x","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T02:33:51Z","timestamp":1748399631000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Siglec6 CAR T cells suppressed progression of AML via inhibiting Siglec6 and SHP2 induced Src and ERK signaling activation"],"prefix":"10.1038","volume":"15","author":[{"given":"Qian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"issue":"2","key":"456_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1182\/blood.2019001239","volume":"135","author":"CD Dinardo","year":"2020","unstructured":"Dinardo, C. D. & Wei, A. H. How I treat acute myeloid leukemia in the era of new drugs [J]. Blood 135 (2), 85\u201396 (2020).","journal-title":"Blood"},{"issue":"3","key":"456_CR2","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ajh.26822","volume":"98","author":"S Shimony","year":"2023","unstructured":"Shimony, S., Stahl, M. & Stone, R. M. Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management [J]. Am. J. Hematol. 98 (3), 502\u2013526 (2023).","journal-title":"Am. J. Hematol."},{"issue":"2","key":"456_CR3","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3324\/haematol.2022.280801","volume":"108","author":"S Kayser","year":"2023","unstructured":"Kayser, S. & Levis, M. J. The clinical impact of the molecular landscape of acute myeloid leukemia [J]. Haematologica 108 (2), 308\u2013320 (2023).","journal-title":"Haematologica"},{"issue":"1","key":"456_CR4","doi-asserted-by":"publisher","first-page":"2248826","DOI":"10.1080\/2162402X.2023.2248826","volume":"12","author":"X Jin","year":"2023","unstructured":"Jin, X. et al. CAR-T cells dual-target CD123 and NKG2DLs to eradicate AML cells and selectively target immunosuppressive cells [J]. Oncoimmunology 12 (1), 2248826 (2023).","journal-title":"Oncoimmunology"},{"issue":"1","key":"456_CR5","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41392-020-00361-x","volume":"5","author":"JL Carter","year":"2020","unstructured":"Carter, J. L. et al. Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy [J]. Signal. Transduct. Target. Therapy. 5 (1), 288 (2020).","journal-title":"Signal. Transduct. Target. Therapy"},{"key":"456_CR6","doi-asserted-by":"crossref","unstructured":"Liu, Y. et al. Development of mRNA lipid nanoparticles: targeting and therapeutic aspects [J]. Int. J. Mol. Sci., 25(18). (2024).","DOI":"10.3390\/ijms251810166"},{"issue":"9","key":"456_CR7","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1002\/cac2.12330","volume":"42","author":"H Lou","year":"2022","unstructured":"Lou, H. & Cao, X. Antibody variable region engineering for improving cancer immunotherapy [J]. Cancer Commun. (London England). 42 (9), 804\u2013827 (2022).","journal-title":"Cancer Commun. (London England)"},{"issue":"1","key":"456_CR8","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1186\/s12967-024-05505-z","volume":"22","author":"Y Jia","year":"2024","unstructured":"Jia, Y. et al. Upregulation of Siglec-6 induces mitochondrial dysfunction by promoting GPR20 expression in early-onset preeclampsia [J]. J. Translational Med. 22 (1), 674 (2024).","journal-title":"J. Translational Med."},{"issue":"2","key":"456_CR9","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/WCO.0000000000000911","volume":"34","author":"A Griciuc","year":"2021","unstructured":"Griciuc, A. & Tanzi, R. E. The role of innate immune genes in Alzheimer\u2019s disease [J]. Curr. Opin. Neurol. 34 (2), 228\u2013236 (2021).","journal-title":"Curr. Opin. Neurol."},{"issue":"4","key":"456_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.21037\/atm-23-1824","volume":"12","author":"AP Urs","year":"2024","unstructured":"Urs, A. P., Goda, C. & Kulkarni, R. Remodeling of the bone marrow microenvironment during acute myeloid leukemia progression [J]. Annals Translational Med. 12 (4), 63 (2024).","journal-title":"Annals Translational Med."},{"issue":"3","key":"456_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3892\/ol.2024.14247","volume":"27","author":"S Meng","year":"2024","unstructured":"Meng, S. et al. Revealing neuropilin expression patterns in pancreatic cancer: from single\u2013cell to therapeutic opportunities (Review) [J]. Oncol. Lett. 27 (3), 113 (2024).","journal-title":"Oncol. Lett."},{"issue":"7","key":"456_CR12","doi-asserted-by":"publisher","first-page":"4263","DOI":"10.1039\/D2RA07472A","volume":"13","author":"Y Hou","year":"2023","unstructured":"Hou, Y. et al. How a single mutation alters the protein structure: a simulation investigation on protein tyrosine phosphatase SHP2 [J]. RSC Adv. 13 (7), 4263\u20134274 (2023).","journal-title":"RSC Adv."},{"issue":"9","key":"456_CR13","doi-asserted-by":"publisher","first-page":"6245","DOI":"10.3390\/curroncol29090491","volume":"29","author":"RJ Stubbins","year":"2022","unstructured":"Stubbins, R. J. et al. Management of acute myeloid leukemia: A review for general practitioners in oncology [J]. Curr. Oncol. (Toronto Ont). 29 (9), 6245\u20136259 (2022).","journal-title":"Curr. Oncol. (Toronto Ont)"},{"key":"456_CR14","doi-asserted-by":"crossref","unstructured":"Yu, J. et al. Clinical Implications of Recurrent Gene Mutations in Acute Myeloid Leukemia [J]94 (Experimental hematology & oncology, 2020).","DOI":"10.1186\/s40164-020-00161-7"},{"issue":"1","key":"456_CR15","doi-asserted-by":"publisher","first-page":"5180","DOI":"10.1038\/s41467-024-48678-3","volume":"15","author":"J Nunes","year":"2024","unstructured":"Nunes, J. et al. Siglec-6 as a therapeutic target for cell migration and adhesion in chronic lymphocytic leukemia [J]. Nat. Commun. 15 (1), 5180 (2024).","journal-title":"Nat. Commun."},{"key":"456_CR16","doi-asserted-by":"crossref","unstructured":"Stefanski, A. L. et al. Siglec-6 signaling uses Src kinase tyrosine phosphorylation and SHP-2 recruitment [J]. Cells, 11(21). (2022).","DOI":"10.3390\/cells11213427"},{"issue":"1","key":"456_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1158\/2159-8290.CD-21-0369","volume":"12","author":"KH Tang","year":"2022","unstructured":"Tang, K. H. et al. Combined Inhibition of SHP2 and CXCR1\/2 promotes antitumor T-cell response in NSCLC [J]. Cancer Discov. 12 (1), 47\u201361 (2022).","journal-title":"Cancer Discov."},{"issue":"1","key":"456_CR18","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12871-024-02641-3","volume":"24","author":"Y Shi","year":"2024","unstructured":"Shi, Y. et al. Remimazolam protects the liver from ischemia-reperfusion injury by inhibiting the MAPK\/ERK pathway [J]. BMC Anesthesiol. 24 (1), 251 (2024).","journal-title":"BMC Anesthesiol."},{"key":"456_CR19","doi-asserted-by":"crossref","unstructured":"Richards, C. E. et al. Protein tyrosine phosphatase Non-Receptor 11 (PTPN11\/Shp2) as a driver oncogene and a novel therapeutic target in Non-Small cell lung Cancer (NSCLC) [J]. Int. J. Mol. Sci. 24(13), 10545 (2023).","DOI":"10.3390\/ijms241310545"},{"issue":"12","key":"456_CR20","doi-asserted-by":"publisher","first-page":"e401","DOI":"10.1371\/journal.pbio.0030401","volume":"3","author":"G Bilousova","year":"2005","unstructured":"Bilousova, G. et al. Impaired DNA replication within progenitor cell pools promotes leukemogenesis [J]. PLoS Biol. 3 (12), e401 (2005).","journal-title":"PLoS Biol."},{"issue":"1","key":"456_CR21","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/s12967-023-04206-3","volume":"21","author":"W Zheng","year":"2023","unstructured":"Zheng, W. et al. Inhalable CART cell-derived exosomes as Paclitaxel carriers for treating lung cancer [J]. J. Translational Med. 21 (1), 383 (2023).","journal-title":"J. Translational Med."},{"issue":"21","key":"456_CR22","doi-asserted-by":"publisher","first-page":"e0082722","DOI":"10.1128\/jvi.00827-22","volume":"96","author":"M Gruenbach","year":"2022","unstructured":"Gruenbach, M. et al. cART restores transient responsiveness to IFN type 1 in HIV-Infected humanized mice [J]. J. Virol. 96 (21), e0082722 (2022).","journal-title":"J. Virol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00456-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00456-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00456-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T02:33:54Z","timestamp":1748399634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00456-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["456"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-00456-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"3 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Ethics Committee of Tianjin Jinke Bona Biotechnology Co. The ethical number is 20230039.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"18611"}}